Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation - Wikidata - awgldk - TriplyDB

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation

http://www.wikidata.org/entity/Q35459531

about

Randomized control trial to evaluate the effects of acute testosterone administration in men on muscle mass, strength, and physical function following ACL reconstructive surgery: rationale, design, methods The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy Testosterone plus low-intensity physical training in late life improves functional performance, skeletal muscle mitochondrial biogenesis, and mitochondrial quality control in male mice Effects of Testosterone Treatment in Older Men.Are we closer to having drugs to treat muscle wasting disease?Optimizing the benefits of exercise on physical function in older adults.Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults.Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases Daily physical activity and physical function in adult maintenance hemodialysis patients.Risk factors associated with cardiovascular events during testosterone administration in older men with mobility limitation.Enobosarm (GTx-024, S-22): a potential treatment for cachexia.Frailty and sarcopenia in elderly.Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Diagnosis and Treatment of Low Testosterone among Patients with End-Stage Renal Disease.Effects of testosterone levels on functional recovery with rehabilitation in stroke patients PHARMACOLOGICAL INTERVENTIONS IN FRAILTY AND SARCOPENIA: REPORT BY THE INTERNATIONAL CONFERENCE ON FRAILTY AND SARCOPENIA RESEARCH TASK FORCE.Treatment of Men for "Low Testosterone": A Systematic Review.Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.Effectiveness of blood flow restricted exercise compared with standard exercise in patients with recurrent low back pain: study protocol for a randomized controlled trial.Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels.Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone Efficacy of whey protein supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function in mobility-limited older adults Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial.Multiple hormonal dysregulation as determinant of low physical performance and mobility in older persons.Psychometric properties of the Late-Life Function and Disability Instrument: a systematic review.Mitochondrial and sex steroid hormone crosstalk during aging.Androgen effects on skeletal muscle: implications for the development and management of frailty.Sex steroids and cardiovascular disease.The Interplay between Magnesium and Testosterone in Modulating Physical Function in Men.Frailty in heart failure.Pharmacologic Options for the Treatment of Sarcopenia.Effects of testosterone administration (and its 5-alpha-reduction) on parenchymal organ volumes in healthy young men: findings from a dose-response trial.Rationale for Strengthening Muscle to Prevent Falls and Fractures: A Review of the Evidence.Treating sarcopenia in clinical practice: where are we now?Androgen deficiency as a biological determinant of frailty: hope or hype?Pulmonary rehabilitation: the reference therapy for undernourished patients with chronic obstructive pulmonary disease Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitation.Improvement of andropause symptoms by dandelion and rooibos extract complex CRS-10 in aging male.

P2860

Q21256713-3490BAEE-8861-475A-8783-D37F3F63DBD1 Q24561868-23D35D21-9B13-4F76-8202-7BF505898DF9 Q26864943-D70C7962-8939-44FB-9F54-7D894DA2DD69 Q27332135-56831112-6F15-4E61-ADA1-04302125A875 Q30833686-8DB4AEB6-C100-4A5F-908C-E99A39372387 Q33741103-7B500FB6-725D-41BD-A27F-568966E70B3B Q33779905-B1054A41-2BD1-4A67-9722-0AFA1C04BF5E Q34073323-834C8E82-E232-42FE-9DC6-7F7D12B7164E Q34145591-C491AED2-71B3-44EA-AB6C-48097578C45B Q34156962-E3F745AF-AEC7-48C8-BE8A-619A713D0380 Q34259431-A078258E-C23D-42D7-B798-7251707761B4 Q34401825-3C145D2F-84E2-44A0-9B79-3935B4D961FC Q34541169-C71888A4-F3C0-4E6C-B0D7-8351FDC57D89 Q34591010-8F01B9AC-D954-4D8D-90C1-2C00A066242D Q35576441-5FEC399D-03A2-430A-BA83-4C69A735E179 Q35943612-7E95719D-DB65-4A42-A163-EB28CCCD8162 Q36040742-5013D150-71C0-47F2-A125-E2C8B7321F79 Q36139976-5CF7B3D3-9909-4F3D-A7AA-35B5B8AC4176 Q36157147-B2F04603-F587-40BF-8DF0-2A4E9BD74C4E Q36430047-2128FBE9-924D-4FA6-AB52-BC4AEE8B83DD Q36574761-ED58FD3E-EA49-4A96-96AD-21AEFC1CB3F2 Q36817175-A3A85F2E-B960-4E22-9E61-2B4117D0C842 Q36965280-6781AE31-072D-4940-9438-EDBB156C12DF Q37003159-71538C21-67A2-4403-97D4-175C604C04FF Q37305834-36696178-A7E5-40DF-B708-7670E42F3438 Q37502104-ACBF1EDF-04F6-4A69-91ED-93B6FD250D40 Q37539827-D09A6B50-11FC-4F56-9F66-384FB8A9D286 Q37580129-3ADF7AED-DC21-4993-B2B9-F22929E180F9 Q37639192-FE75B97D-CA55-41F1-BDE9-F4E941CDA84A Q37639200-95404640-E346-4B9F-8661-4523FCBFA98D Q37645065-6BA53ACB-3013-43EF-8E82-4D50800E3399 Q38204701-611C4AE1-D7A4-4A51-A0F7-83945F122AB3 Q38534875-DBD0BC4E-989F-42BD-A837-EBD6D76C82BE Q38680823-E13BEB6B-DB85-44BF-8E3B-C7F330081C69 Q38723625-8BFCA0F0-14AB-4D9F-812F-C4A46441A8A6 Q38817017-F85E2C58-9E93-482A-894F-1938A51DEBDA Q39180731-8E828EB8-88A3-4A88-BED8-7AAA32B86C45 Q39216001-141E3CB5-A456-42BE-ADB9-D8DFD562149D Q40209980-011DF0E4-561A-4BDE-A40A-C5A390FDF04A Q41908924-51970095-F1B2-4043-8C57-2F465D8C0E13

P2860

Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation

http://www.wikidata.org/entity/Q35459531

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Clinical meaningfulness of the ...... r men with mobility limitation

@ast

Clinical meaningfulness of the ...... r men with mobility limitation

@en

type

label

Clinical meaningfulness of the ...... r men with mobility limitation

@ast

Clinical meaningfulness of the ...... r men with mobility limitation

@en

prefLabel

Clinical meaningfulness of the ...... r men with mobility limitation

@ast

Clinical meaningfulness of the ...... r men with mobility limitation

@en

P1433

Q35459531-387CB67C-B8E4-4709-85F7-FF73E8C86788

P1476

Q35459531-D2D2525E-C8D1-4E99-A55F-45CCEEBFA260

P2093

Q35459531-09ED0F63-A91F-4CA6-A0D1-303DDC51D695

Q35459531-1055C0E8-9D8B-4FB0-BAF8-E73E782B427C

Q35459531-2CB72D8D-00FE-4B55-8955-72816BAA79CF

Q35459531-2DD95DD3-9054-4EE9-AF5B-B75755006342

Q35459531-314228EB-4A4B-494F-846E-2B6F7DE6E70F

Q35459531-3A0F61E3-410A-4252-A542-C8207FFB4F16

Q35459531-48F0E48F-2054-4FF0-9E08-8C4412931C7B

Q35459531-67EDB56A-A1E5-4D35-8910-473934FBD7AD

Q35459531-7308FEEE-90EA-425F-98DE-A1252A1475EB

Q35459531-7561C812-A88F-4D64-BB43-6F3640D9E6D5

P2860

Q35459531-0BF27081-A692-42F6-857C-F461B999622D

Q35459531-114E71D3-3390-460C-854D-423F36835F71

Q35459531-193EEDB0-F24B-4D35-8626-F2002F30703C

Q35459531-1BF542F8-DB9B-4376-B175-6CC6A46A4169

Q35459531-1FFB214B-87B6-4D15-B9DF-119C14433DBA

Q35459531-214526F2-A83D-44B7-9535-B58987A927C8

Q35459531-23ADD9BC-431E-4A9B-B6C0-F9D90C7A9BF9

Q35459531-2A8DA9DA-8913-4A0B-B2E3-443F6849A53D

Q35459531-412B4CAC-3755-47BB-85E4-A2B7E970168C

Q35459531-4B827F6D-7307-4E9A-8864-3043D5CF6485

P304

Q35459531-BA72B662-0316-4D29-A78D-9FA6D3DA8BAD

P31

Q35459531-9553D1F3-CF42-48C9-8993-00630A2E72C5

P356

Q35459531-86681AB6-2E44-4A66-827A-0B2CBC4C03EC

P407

Q35459531-5EEE484E-56DF-4238-9913-7EAD82F19239

P433

Q35459531-AE80BEEA-701E-4B9A-AC06-060D3F5D3AF2

P478

Q35459531-23D1983B-586E-4740-82B3-B12918119D53

P50

Q35459531-0610BF43-1656-4876-8CB1-809D6EE46806

Q35459531-06676627-060B-46BA-80E6-0CFE50841567

Q35459531-48E5FF11-02AF-49FF-88CB-74B57C6A83B3

Q35459531-9C03FBCA-4838-4061-8B98-372ECA0A5256

Q35459531-AE4F6889-E3B0-4D9C-9587-5B5F7FDF1BF3

Q35459531-B02A7946-7198-40B5-9C69-0E7B6EA9DCE1

Q35459531-EBE1334E-378E-4A25-8E5A-A9FD8F39F929

Q35459531-F90C3C79-8E2E-4438-8B87-7310157B631C

P577

Q35459531-3DD0839E-FE90-4164-9B28-68228E7ABB29

P5875

Q35459531-E868DD49-F7DE-4F86-A2A7-399FA5CE4F36

P698

Q35459531-4AB7D750-4B17-4D4E-A6FA-16C3213B752C

P932

Q35459531-590AC738-3040-4FCA-A306-CE8A0D189229

P356

P1433

The Journals of Gerontology

P1476

Clinical meaningfulness of the ...... r men with mobility limitation

@en

P2093

Ahn-Hoa Nguyen

http://www.w3.org/2001/XMLSchema#string

Antonio Lazzari

http://www.w3.org/2001/XMLSchema#string

Ashmeet Bhatia

http://www.w3.org/2001/XMLSchema#string

Ayan Elmi

http://www.w3.org/2001/XMLSchema#string

Brad Brooks

http://www.w3.org/2001/XMLSchema#string

Erica Appleman

http://www.w3.org/2001/XMLSchema#string

Geeta Bhasin

http://www.w3.org/2001/XMLSchema#string

Jagadish Ulloor

http://www.w3.org/2001/XMLSchema#string

Karen Choong

http://www.w3.org/2001/XMLSchema#string

Kishore Lakshman

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse events associated with testosterone administration

Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study.

Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.

Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.

Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study

DHEA in elderly women and DHEA or testosterone in elderly men.

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty.

Effects of testosterone therapy on muscle performance and physical function in older men with mobility limitations (The TOM Trial): design and methods.

Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

P304

1090-1099

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GERONA/GLR100

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Shehzad Basaria

Andrea D Coviello

Nathan K. LeBrasseur

Shalender Bhasin

P577

2011-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51242515

http://www.w3.org/2001/XMLSchema#string

P698

21697501

http://www.w3.org/2001/XMLSchema#string

P932

3202898

http://www.w3.org/2001/XMLSchema#string